Skip to main content
. Author manuscript; available in PMC: 2015 Sep 7.
Published in final edited form as: Cell Transplant. 2014 Mar 7;24(8):1599–1614. doi: 10.3727/096368914X678571

Table 1.

Characteristics of islet-transplanted patients and healthy volunteers. Data are expressed as mean±SD.

Healthy
volunteers
(n=10)
T1D
Patients
(n=10)
Islet-
transplanted
patients
(n=10)
Gender (M/F) 7/3 4/6 7/3
Age (years) 40.3±7.7 43.7±6.0 45.3±3.9
T1D (years) - 24.2±8 27.0±8.1
C-peptide (ng/ml) - 0.01±0.3 1.7±0.5
EIR (U/day) - 30±4.2 8.8±2
HbA1c(%) - 8.7±1.1 6.8±1.0
Time from last islet infusion (months) - - 32.6±11.6
Rapamycin+FK506 - - 5/10
FK506+Mycophenolate - - 4/10
Rapamycin+Azathioprine - - 1/10

T1D (type 1 diabetes); EIR (exogenous insulin requirement); HbA1c (glycated hemoglobin).